Inventor · disambiguated record
Anna P. Tretiakova
Also filed as: TRETIAKOVA ANNA · TRETIAKOVA ANNA P
18 granted patents·19 pending applications·107 citations·filing 2008–2023
93Inventor score
Files withUNIV PENNSYLVANIA23ASKLEPIOS BIOPHARMACEUTICAL INC5INTREXON CORP4SWANBIO THERAPEUTICS LTD2REED THOMAS1
Top patents by PatentIndex Score
37 records- 0196US9719106B2Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereofUNIV PENNSYLVANIA·Filed 2014·Granted Aug 1, 2017·36 cites·13 claims
- 0295US10786568B2AAV mediated influenza vaccinesUNIV PENNSYLVANIA·Filed 2018·Granted Sep 29, 2020·16 cites·18 claims
- 0394US10647758B2Compositions comprising AAV expressing dual antibody constructs and uses thereofUNIV PENNSYLVANIA·Filed 2019·Granted May 12, 2020·8 cites·25 claims
- 0493US11197937B2Compositions for treatment of wet age-related macular degenerationUNIV PENNSYLVANIA·Filed 2017·Granted Dec 14, 2021·8 cites·5 claims
- 0590US10647998B2Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereofUNIV PENNSYLVANIA·Filed 2017·Granted May 12, 2020·4 cites·22 claims
- 0690US10138295B2Compositions comprising AAV expressing dual antibody constructs and uses thereofUNIV PENNSYLVANIA·Filed 2015·Granted Nov 27, 2018·8 cites·21 claims
- 0789US10385119B2Compositions comprising AAV expressing dual antibody constructs and uses thereofUNIV PENNSYLVANIA·Filed 2018·Granted Aug 20, 2019·6 cites·17 claims
- 0885US9315825B2Pharmacologically induced transgene ablation systemWILSON JAMES M·Filed 2011·Granted Apr 19, 2016·15 cites·26 claims
- 0982US11779655B2AAV-ABCD1 constructs and use for treatment or prevention of adrenoleukodystrophy (ALD) and/or adrenomyeloneuropathy (AMN)SWANBIO THERAPEUTICS LTD·Filed 2021·Granted Oct 10, 2023·2 cites·15 claims
- 1081US9724430B2Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereofINTREXON CORP·Filed 2015·Granted Aug 8, 2017·3 cites·4 claims
- 1172US12023386B2Composition for treatment of Crigler-Najjar syndromeUNIV PENNSYLVANIA·Filed 2021·Granted Jul 2, 2024·0 cites·18 claims
- 1271US10975140B2Compositions comprising AAV expressing dual antibody constructs and uses thereofUNIV PENNSYLVANIA·Filed 2020·Granted Apr 13, 2021·0 cites·17 claims
- 1370US11535665B2AAV-mediated expression of anti-influenza antibodies and methods of use thereofUNIV PENNSYLVANIA·Filed 2016·Granted Dec 27, 2022·1 cites·21 claims
- 1468US2023331826A1Aav-mediated expression of anti-influenza antibodies and methods of use thereofUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 1565US2024350595A1Compositions comprising a lecithin cholesterol acyltransferase variant and uses thereofUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 1664US2025213726A1Therapeutic adeno-associated virus using codon optimized nucleic acid encoding alpha-glucosidase (gaa) for treating pompe disease, with signal peptide modificationsASKLEPIOS BIOPHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 1764US2025161493A1Compositions and methods for in vivo nuclease-mediated treatment of ornithine transcarbamylase (otc) deficiencyUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 1863US2024197916A1Compositions and methods for in vivo nuclease-mediated gene targeting for the treatment of genetic disordersUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 1963US2022288238A1Compositions for treatment of wet age-related macular degenerationUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 2062US2009136465A1Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses ThereofINTREXON CORP·Filed 2008·Application pending·0 cites
- 2162US2024009326A1Aav-abcd1 constructs and use for treatment or prevention of adrenoleukodystrophy (ald) and/or adrenomyeloneuropathy (amn)SWANBIO THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 2260US2019343967A1Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses ThereofINTREXON CORP·Filed 2019·Application pending·0 cites
- 2359US11241506B2Composition for treatment of Crigler-Najjar syndromeUNIV PENNSYLVANIA·Filed 2016·Granted Feb 8, 2022·0 cites·22 claims
- 2459US10314926B2Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereofINTREXON CORP·Filed 2017·Granted Jun 11, 2019·0 cites·4 claims
- 2558US2020390888A1Novel aav mediated influenza vaccinesUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 2657US11883470B2Compositions comprising a lecithin cholesterol acyltransferase variant and uses thereofUNIV PENNSYLVANIA·Filed 2017·Granted Jan 30, 2024·0 cites·25 claims
- 2756US2025109398A1Compositions for treating neurological diseaseASKLEPIOS BIOPHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 2855US8455628B2PP1 ligandsREED THOMAS·Filed 2008·Granted Jun 4, 2013·0 cites·18 claims
- 2954US2023365963A1Methods for treating neurological diseaseASKLEPIOS BIOPHARMACEUTICAL INC·Filed 2021·Application pending·0 cites
- 3053US2023374542A1Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy. disorders including limb girdle 21 (lgmd21)ASKLEPIOS BIOPHARMACEUTICAL INC·Filed 2021·Application pending·0 cites
- 3152US2023340528A1Methods of treating cardiac disorders and congestive heart failure and administering aav vectorsTRETIAKOVA ANNA·Filed 2021·Application pending·0 cites
- 3247US11401527B2Compositions and methods useful for prophylaxis of organophosphatesUNIV PENNSYLVANIA·Filed 2017·Granted Aug 2, 2022·0 cites·13 claims
- 3344US2023038520A1Therapeutic adeno-associated virus comprising liver-specific promoters for treating pompe disease and lysosomal disordersASKLEPIOS BIOPHARMACEUTICAL INC·Filed 2020·Application pending·0 cites
- 3443US2017000904A1Pharmacologically induced transgene ablation systemUNIV PENNSYLVANIA·Filed 2016·Application pending·0 cites
- 3539US2019002915A1Compositions and methods for regulatable antibody expressionUNIV PENNSYLVANIA·Filed 2016·Application pending·0 cites
- 3638US2019240328A1Novel humanized anti-ebola antibodies useful in preventing ebola infectionsUNIV PENNSYLVANIA·Filed 2017·Application pending·0 cites
- 3738US2013023033A1Pharmacologically induced transgene ablation systemUNIV PENNSYLVANIA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anna P. Tretiakova files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →